PLATFORM TECHNOLOGY

The innovative microfluidics-based drug discovery engine 

(AmberFlow    ) integrates patent-protected systems and methods with our deep understanding of immunology. By unlocking the power of single-cell function analysis in a tunable microenvironment, the AmberFlow platform enables the decidedly efficient isolation of rare high-quality and well-characterized antibody drug candidates.

TM

PIPELINE

We are developing first-in-class immunotherapeutic pipeline assets each with significant differentiation.
 

PUBLICATIONS

Functional TCR T cell screening using single-cell droplet microfluidics.
Segaliny A., et al.  Lab Chip,  2018, 18:3733-3749.
 

© 2020 Amberstone Biosciences